| Primary |
| Breast Cancer |
55.6% |
| Product Used For Unknown Indication |
14.3% |
| Breast Cancer Metastatic |
5.9% |
| Hypertension |
5.7% |
| Breast Cancer Female |
3.1% |
| Depression |
2.1% |
| Hyperlipidaemia |
1.5% |
| Arrhythmia |
1.3% |
| Osteoporosis |
1.3% |
| Diabetes Mellitus |
1.1% |
| Dyspepsia |
1.1% |
| Adjuvant Therapy |
1.0% |
| Chemotherapy |
1.0% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Hypothyroidism |
0.8% |
| Prophylaxis |
0.8% |
| Antioestrogen Therapy |
0.7% |
| Anxiety |
0.7% |
| Asthma |
0.7% |
| Bipolar Disorder |
0.7% |
|
| Suicidal Ideation |
12.6% |
| Adverse Drug Reaction |
6.9% |
| Pain In Extremity |
6.3% |
| Arthralgia |
5.7% |
| Product Substitution Issue |
5.7% |
| Pulmonary Embolism |
5.7% |
| Alopecia |
5.1% |
| Memory Impairment |
5.1% |
| Pain |
5.1% |
| Quality Of Life Decreased |
4.6% |
| Rash |
4.6% |
| Sjogren's Syndrome |
4.6% |
| Vomiting |
4.6% |
| Weight Increased |
4.6% |
| Hallucination, Visual |
4.0% |
| Vertigo Positional |
3.4% |
| Drug Ineffective |
2.9% |
| Musculoskeletal Pain |
2.9% |
| Papilloedema |
2.9% |
| Transient Acantholytic Dermatosis |
2.9% |
|
| Secondary |
| Breast Cancer |
53.5% |
| Product Used For Unknown Indication |
10.1% |
| Hypertension |
7.4% |
| Drug Use For Unknown Indication |
7.1% |
| Osteoporosis |
4.2% |
| Breast Cancer Metastatic |
3.9% |
| Acute Myeloid Leukaemia |
2.0% |
| Breast Cancer Female |
1.6% |
| Invasive Lobular Breast Carcinoma |
1.0% |
| Metastases To Bone |
1.0% |
| Metastatic Neoplasm |
1.0% |
| Blood Cholesterol Increased |
0.9% |
| Myeloproliferative Disorder |
0.9% |
| Analgesic Therapy |
0.8% |
| Breast Cancer Stage Iv |
0.8% |
| Chemotherapy |
0.8% |
| Haemorrhoids |
0.8% |
| Hormone Therapy |
0.8% |
| Hypothyroidism |
0.8% |
| Ill-defined Disorder |
0.8% |
|
| Sudden Death |
10.9% |
| Hyponatraemia |
9.8% |
| Weight Decreased |
9.8% |
| Hip Fracture |
6.5% |
| Aplastic Anaemia |
5.4% |
| Myocardial Ischaemia |
5.4% |
| Arthralgia |
4.3% |
| Myocardial Infarction |
4.3% |
| Pulmonary Embolism |
4.3% |
| Sepsis |
4.3% |
| Ventricular Extrasystoles |
4.3% |
| Vomiting |
4.3% |
| Acute Myeloid Leukaemia |
3.3% |
| Cutaneous Vasculitis |
3.3% |
| Deep Vein Thrombosis |
3.3% |
| Hepatitis Cholestatic |
3.3% |
| Myelodysplastic Syndrome |
3.3% |
| Nephrogenic Anaemia |
3.3% |
| Nuclear Magnetic Resonance Imaging Abnormal |
3.3% |
| Osteolysis |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.7% |
| Breast Cancer |
21.4% |
| Drug Use For Unknown Indication |
9.4% |
| Hypertension |
7.4% |
| Metastases To Bone |
7.0% |
| Breast Cancer Metastatic |
5.5% |
| Pain |
4.5% |
| Depression |
3.0% |
| Osteoporosis |
2.4% |
| Blood Cholesterol Increased |
2.1% |
| Fibromyalgia |
1.8% |
| Hormone Replacement Therapy |
1.8% |
| Smoking Cessation Therapy |
1.6% |
| Anxiety |
1.5% |
| Neuralgia |
1.5% |
| Diabetes Mellitus |
1.4% |
| Prophylaxis |
1.4% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Chemotherapy |
1.2% |
| Rheumatoid Arthritis |
1.1% |
|
| Weight Decreased |
11.4% |
| Tooth Extraction |
7.9% |
| Breast Cancer |
7.5% |
| Nausea |
6.4% |
| Vomiting |
6.1% |
| Weight Increased |
6.1% |
| Somnolence |
5.4% |
| Vision Blurred |
5.4% |
| Oral Pain |
5.0% |
| Osteonecrosis |
4.3% |
| Syncope |
3.9% |
| X-ray Abnormal |
3.9% |
| Death |
3.6% |
| Diarrhoea |
3.6% |
| Thrombocytopenia |
3.6% |
| Delirium |
3.2% |
| Gastrointestinal Haemorrhage |
3.2% |
| Hypertension |
3.2% |
| Myocardial Infarction |
3.2% |
| Pain In Extremity |
3.2% |
|
| Interacting |
| Breast Cancer |
45.7% |
| Metastasis |
22.2% |
| Product Used For Unknown Indication |
14.8% |
| Delirium |
3.7% |
| Bone Pain |
2.5% |
| Hormone Therapy |
2.5% |
| Neoplasm Malignant |
2.5% |
| Arthralgia |
1.2% |
| Breast Cancer Metastatic |
1.2% |
| Hyperlipidaemia |
1.2% |
| Pain In Extremity |
1.2% |
| Sedation |
1.2% |
|
| Osteonecrosis |
60.0% |
| Drug Interaction |
20.0% |
| Low Density Lipoprotein Increased |
20.0% |
|
